IONIS PHARMACEUTICALS INC ($IONS)
Filing Information
| Accession Number | 0000874015-26-000072 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 15, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
88,587
Total Value
$748,383.09
P&L
+inf% (+$2,534,343.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP Research | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 21,366 | $0.00 | $0.00 | 51,819 | Direct | โ | View Details | |
EVP Research | Common Stock | โ | Jan 16, 2026 | Sale | 9,884 | $75.34 | $744,660.56 | 41,935 | Direct | โ | View Details | |
EVP Research | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 111 | $0.00 | $0.00 | 367 | Indirect | by Son | View Details | |
EVP Research | Common Stock | โ | Jan 16, 2026 | Sale | 49 | $75.97 | $3,722.53 | 318 | Indirect | by Son | View Details | |
EVP Research | Performance Restricted Stock Units | Derivative | Jan 15, 2026 | Grant/Award | 25,800 | $0.00 | $0.00 | 90,282 | Direct | โ | View Details | |
EVP Research | Restricted Stock Unit | Derivative | Jan 15, 2026 | Exercise/Conversion | 21,366 | $0.00 | $0.00 | 39,251 | Direct | โ | View Details | |
EVP Research | Restricted Stock Unit | Derivative | Jan 15, 2026 | Grant/Award | 9,675 | $0.00 | $0.00 | 48,926 | Direct | โ | View Details | |
EVP Research | Restricted Stock Unit | Derivative | Jan 15, 2026 | Exercise/Conversion | 111 | $0.00 | $0.00 | 386 | Indirect | by Son | View Details | |
EVP Research | Restricted Stock Unit | Derivative | Jan 15, 2026 | Grant/Award | 225 | $0.00 | $0.00 | 611 | Indirect | by Son | View Details |